Department of Epileptology, University of Bonn, D-53127 Bonn, Germany.
Brain. 2011 Oct;134(Pt 10):2844-54. doi: 10.1093/brain/awr204. Epub 2011 Sep 5.
Focal cortical dysplasias type II (FCD II) are highly epileptogenic lesions frequently causing pharmacoresistant epilepsy. Detection of these lesions on MRI is still challenging as FCDs may be very subtle in appearance and might escape conventional visual analysis. Morphometric MRI analysis is a voxel-based post-processing method based on algorithms of the statistical parametric mapping software (SPM5). It creates three dimensional feature maps highlighting brain areas with blurred grey-white matter junction and abnormal gyration, and thereby may help to detect FCD. In this study, we evaluated the potential diagnostic value of morphometric analysis as implemented in a morphometric analysis programme, compared with conventional visual analysis by an experienced neuroradiologist in 91 patients with histologically proven FCD II operated on at the University Hospital of Bonn between 2000 and 2010 (FCD IIa, n = 17; IIb, n = 74). All preoperative MRI scans were evaluated independently (i) based on conventional visual analysis by an experienced neuroradiologist and (ii) using morphometric analysis. Both evaluators had the same clinical information (electroencephalography and semiology), but were blinded to each other's results. The detection rate of FCD using morphometric analysis was superior to conventional visual analysis in the FCD IIa subgroup (82% versus 65%), while no difference was found in the FCD IIb subgroup (92% versus 91%). However, the combination of conventional visual analysis and morphometric analysis provided complementary information and detected 89 out of all 91 FCDs (98%). The combination was significantly superior to conventional visual analysis alone in both subgroups resulting in a higher diagnostic sensitivity (94% versus 65%, P = 0.031 for FCD IIa; 99% versus 91%, P = 0.016 for FCD IIb). In conclusion, the additional application of morphometric MRI analysis increases the diagnostic sensitivity for FCD II in comparison with conventional visual analysis alone. Since detection of FCDs on MRI during the presurgical evaluation markedly improves the chance of becoming seizure free postoperatively, we apply morphometric analysis in all patients who are MRI-negative after conventional visual analysis at our centre.
局灶性皮质发育不良 II 型(FCD II)是高度致痫性病变,常导致药物难治性癫痫。MRI 上检测这些病变仍然具有挑战性,因为 FCD 在外观上可能非常细微,可能会逃脱常规的视觉分析。形态测量 MRI 分析是一种基于统计参数映射软件(SPM5)算法的基于体素的后处理方法。它创建三维特征图,突出显示灰白质交界模糊和异常回旋的脑区,从而有助于检测 FCD。在这项研究中,我们评估了形态测量分析在 91 例经组织学证实的 FCD II 患者中的应用价值,这些患者于 2000 年至 2010 年在波恩大学医院接受手术治疗(FCD IIa,n=17;FCD IIb,n=74)。所有术前 MRI 扫描均由一位经验丰富的神经放射科医生独立进行(i)基于常规视觉分析,(ii)使用形态测量分析。两位评估者均具有相同的临床信息(脑电图和半定量分析),但彼此的结果均为盲法。形态测量分析对 FCD IIa 亚组的 FCD 检测率优于常规视觉分析(82%对 65%),而 FCD IIb 亚组无差异(92%对 91%)。然而,常规视觉分析与形态测量分析相结合提供了互补信息,并检测到 91 例 FCD 中的 89 例(98%)。该组合在两个亚组中的诊断敏感性均明显高于单独使用常规视觉分析(94%对 65%,P=0.031,FCD IIa;99%对 91%,P=0.016,FCD IIb)。总之,与单独使用常规视觉分析相比,形态测量 MRI 分析的额外应用增加了 FCD II 的诊断敏感性。由于在术前评估中 MRI 上检测到 FCD 明显提高了术后无癫痫发作的机会,因此我们在中心对所有常规视觉分析后 MRI 阴性的患者均应用形态测量分析。